State of Alaska Department of Revenue Acquires Shares of 5,791 Lantheus Holdings, Inc. (LNTH)
State of Alaska Department of Revenue acquired a new position in shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 5,791 shares of the medical equipment provider’s stock, valued at approximately $102,000.
Several other hedge funds and other institutional investors also recently made changes to their positions in LNTH. Capstone Asset Management Co. bought a new position in shares of Lantheus Holdings during the second quarter worth about $286,000. Capital One National Association boosted its position in shares of Lantheus Holdings by 79.6% in the second quarter. Capital One National Association now owns 123,993 shares of the medical equipment provider’s stock worth $2,188,000 after buying an additional 54,943 shares during the period. Goldman Sachs Group Inc. boosted its position in shares of Lantheus Holdings by 329.8% in the first quarter. Goldman Sachs Group Inc. now owns 171,742 shares of the medical equipment provider’s stock worth $2,147,000 after buying an additional 131,779 shares during the period. FNY Partners Fund LP bought a new position in shares of Lantheus Holdings during the first quarter worth about $174,000. Finally, Tudor Investment Corp ET AL bought a new position in shares of Lantheus Holdings during the first quarter worth about $938,000. 66.32% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) traded up 6.39% on Friday, hitting $19.15. The stock had a trading volume of 602,282 shares. The company has a 50 day moving average price of $18.03 and a 200-day moving average price of $14.22. The stock has a market cap of $715.25 million, a PE ratio of 26.16 and a beta of 0.91. Lantheus Holdings, Inc. has a 12 month low of $6.62 and a 12 month high of $20.45.
Lantheus Holdings (NASDAQ:LNTH) last announced its earnings results on Tuesday, August 1st. The medical equipment provider reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.18. The firm had revenue of $88.83 million for the quarter, compared to analysts’ expectations of $80.56 million. Lantheus Holdings had a net margin of 8.44% and a negative return on equity of 37.47%. The business’s revenue was up 13.9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.24 EPS. On average, equities research analysts anticipate that Lantheus Holdings, Inc. will post $1.07 earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: “State of Alaska Department of Revenue Acquires Shares of 5,791 Lantheus Holdings, Inc. (LNTH)” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/08/13/state-of-alaska-department-of-revenue-acquires-shares-of-5791-lantheus-holdings-inc-lnth.html.
A number of brokerages have recently issued reports on LNTH. Zacks Investment Research raised Lantheus Holdings from a “hold” rating to a “strong-buy” rating and set a $18.00 price objective on the stock in a research note on Thursday, August 3rd. Credit Suisse Group raised their price objective on Lantheus Holdings from $14.00 to $19.00 and gave the company a “neutral” rating in a research note on Wednesday, August 2nd. Jefferies Group LLC reaffirmed a “buy” rating and set a $22.00 price objective (up from $18.00) on shares of Lantheus Holdings in a research note on Wednesday, August 2nd. Finally, Cantor Fitzgerald began coverage on Lantheus Holdings in a research note on Monday, July 17th. They set an “overweight” rating and a $22.00 price objective on the stock. One analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. Lantheus Holdings presently has an average rating of “Buy” and an average target price of $18.60.
In other news, Director David F. Burgstahler sold 3,000,000 shares of the company’s stock in a transaction dated Tuesday, June 20th. The shares were sold at an average price of $14.87, for a total transaction of $44,610,000.00. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Mary Anne Heino sold 10,000 shares of the company’s stock in a transaction dated Monday, June 12th. The shares were sold at an average price of $15.39, for a total transaction of $153,900.00. Following the sale, the chief executive officer now owns 602,468 shares in the company, valued at $9,271,982.52. The disclosure for this sale can be found here. Insiders have sold a total of 3,040,000 shares of company stock worth $45,252,800 over the last 90 days. Corporate insiders own 2.30% of the company’s stock.
Lantheus Holdings Company Profile
Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.
Want to see what other hedge funds are holding LNTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lantheus Holdings, Inc. (NASDAQ:LNTH).
Receive News & Stock Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related stocks with our FREE daily email newsletter.